Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry Ponich

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 10, 2005
Long-term follow-up of trigger point injections for abdominal wall painJose Nazareno, Terry Ponich, Jamie Gregor
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 10, 2005
A survey of Canadian gastroenterologists about the use of methotrexate in patients with Crohn's diseaseNilesh Chande, Terry Ponich, James Gregor
International Journal of Microbiology|December 30, 2014
Candida glabrata Esophagitis: Are We Seeing the Emergence of a New Azole-Resistant Pathogen?Aze Wilson, Johan Delport, Terry Ponich
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|April 4, 2002
Are patients informed when they consent to ERCP?Sinead O'Sullivan, Craig Crippen, Terry Ponich
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|July 4, 2002
Musculoskeletal injuries among ERCP endoscopists in CanadaSinead O'Sullivan, Gary Bridge, Terry Ponich
Scandinavian Journal of Gastroenterology|April 21, 2017
The utility of fecal calprotectin in predicting the need for escalation of therapy in inflammatory bowel diseaseLukasz Kwapisz, Jamie Gregor, Nilesh Chande, et al.
Scandinavian Journal of Gastroenterology|December 17, 2013
The safety and efficacy of adalimumab in patients with Crohn's disease: the experience of a single Canadian tertiary care centreAnouar Teriaky, James Gregor, Brian Yan, et al.
Inflammatory Bowel Diseases|September 16, 2022
Decreased Infliximab Concentrations in Patients With Inflammatory Bowel Disease Who Carry a Variable Number Tandem Repeat Polymorphism in the Neonatal Fc Receptor or Variant HLADQA1*05G>A GenotypeBethany Choi, Michael Sey, Terry Ponich, et al.
BMC Gastroenterology|February 19, 2021
High infliximab trough concentrations are associated with sustained histologic remission in inflammatory bowel disease: a prospective cohort studyAze Wilson, Bethany Choi, Michael Sey, et al.
World Journal of Gastroenterology|January 13, 2010
Predictors of disease severity in ulcerative colitis patients from Southwestern OntarioLee S Roth, Nilesh Chande, Terry Ponich, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 10, 2005
Long-term follow-up of trigger point injections for abdominal wall painJose Nazareno, Terry Ponich, Jamie Gregor
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 10, 2005
A survey of Canadian gastroenterologists about the use of methotrexate in patients with Crohn's diseaseNilesh Chande, Terry Ponich, James Gregor
International Journal of Microbiology|December 30, 2014
Candida glabrata Esophagitis: Are We Seeing the Emergence of a New Azole-Resistant Pathogen?Aze Wilson, Johan Delport, Terry Ponich
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|April 4, 2002
Are patients informed when they consent to ERCP?Sinead O'Sullivan, Craig Crippen, Terry Ponich
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|July 4, 2002
Musculoskeletal injuries among ERCP endoscopists in CanadaSinead O'Sullivan, Gary Bridge, Terry Ponich
Scandinavian Journal of Gastroenterology|April 21, 2017
The utility of fecal calprotectin in predicting the need for escalation of therapy in inflammatory bowel diseaseLukasz Kwapisz, Jamie Gregor, Nilesh Chande, et al.
Scandinavian Journal of Gastroenterology|December 17, 2013
The safety and efficacy of adalimumab in patients with Crohn's disease: the experience of a single Canadian tertiary care centreAnouar Teriaky, James Gregor, Brian Yan, et al.
Inflammatory Bowel Diseases|September 16, 2022
Decreased Infliximab Concentrations in Patients With Inflammatory Bowel Disease Who Carry a Variable Number Tandem Repeat Polymorphism in the Neonatal Fc Receptor or Variant HLADQA1*05G>A GenotypeBethany Choi, Michael Sey, Terry Ponich, et al.
BMC Gastroenterology|February 19, 2021
High infliximab trough concentrations are associated with sustained histologic remission in inflammatory bowel disease: a prospective cohort studyAze Wilson, Bethany Choi, Michael Sey, et al.
World Journal of Gastroenterology|January 13, 2010
Predictors of disease severity in ulcerative colitis patients from Southwestern OntarioLee S Roth, Nilesh Chande, Terry Ponich, et al.
Pageof 3